Medical Perfusion Technology Market to Grow at a CAGR of 4.1% to reach US$ 962.60 Million from 2020 to 2027

Medical Perfusion Technology Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Technique (Hypothermic Machine Perfusion and Normothermic Machine Perfusion), Organ Type (Heart, Lung, Kidney, and Liver), and Component (Perfusion Pumps, Oxygenators, Heart-Lung Machines, Monitoring Systems, Cannulas, and Others), and Geography

Publication Month : Mar 2021

  • Report Code : TIPRE00019844
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 173
Inquire Before Buy




The medical perfusion technology market is expected to reach US$ 962.60 million by 2027 from US$ 707.10 million in 2019. The market is estimated to grow at a CAGR of 4.1% from 2020 to 2027.

The scope of the medical perfusion technology market includes technique, organ type, component, and region. The market for medical perfusion technology, based on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the medical perfusion technology market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world. It also includes COVID–19 impact analysis across all the regions.

Lucrative Regions for Medical Perfusion Technology Market

Lucrative Regions for Medical Perfusion Technology Market
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Market Insights

Perfusion Instruments for Cell-based Research Activities

Rise in chronic conditions and advantages of the applications of biotechnology are extensively boosting the cell-based research activities. The cell-based assays play a vital role in understanding various challenges of biology of the living organisms, such as cell signaling, proliferation, apoptosis, cellular genetics, neurology, and cancer.

The cell-based assays are extensively carried out in pharmaceutical, biotechnology industries, research institutes, and academics research institutes. The pharmaceutical and biopharmaceutical industries use cell-based assays to efficiently commercialize a drug.

The cell-based assays are also extensively carried out by the contract research organizations for the clinical trial studies and other processes. Chronic diseases such as cancer and other genetic related studies are accelerating the demand for the cell-based studies. For instance, Charles River offers services for the human primary cell-based assays. According to an article published by the company, the developments in the cell-based assays are likely to continue in the future. Moreover, the company states that the cell-based assays are helpful in the drug discovery as the in vitro to in vivo correlation plays a vital role in the drug development. Thus, the increasing cell-based research activities are likely to drive the medical perfusion technology market during the forecast period.

Technique-Based Insights

Based on technique, the medical perfusion technology market is segmented into hypothermic machine perfusion and normothermic machine perfusion. The hypothermic machine perfusion segment held larger share of the market in 2019. However, the normothermic machine perfusion segment is estimated to register higher CAGR of 4.4% in the market during the forecast period.

Global Medical Perfusion Technology Market, by Technique – 2019 & 2027

Global Medical Perfusion Technology Market, by Technique – 2019 & 2027
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Organ Type-Based Insights

Based on organ type, the medical perfusion technology market is segmented into heart, lung, kidney, and liver. The kidney segment held the largest share of the market in 2019. However, the heart segment is estimated to register the highest CAGR of 4.8% in the market during the forecast period.

Component-Based Insights

Based on component, the medical perfusion technology market is segmented into perfusion pumps, oxygenators, heart-lung machines, monitoring systems, cannulas, and others. In 2019, the oxygenators segment held the largest share of the market, by component. In addition, the segment is also expected to grow at the fastest rate during the coming years owing to the increasing number of cardiovascular surgeries, liver transplantation, and kidney transplantation.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Medical Perfusion Technology Market: Strategic Insights

Market Size Value inUS$ 707.10 Million in 2019
Market Size Value byUS$ 962.60 Million by 2027
Growth rateCAGR of 4.1% from 2020-2027
Forecast Period2020-2027
Base Year2020
Analyst Image


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Inorganic strategies such as partnerships and mergers & acquisitions are commonly adopted by companies to cater to changing customer demand and maintain their brand name across the world. Market players operating in the medical perfusion technology market also adopt organic strategies such as product launch and expansion to outstretch their footprint and product portfolio worldwide as well as to meet the growing demand.

By Technique

  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion

By Organ Type

  • Heart
  • Lung
  • Kidney
  • Liver
  • Others

By Component

  • Perfusion Pumps
  • Oxygenators
  • Heart-Lung Machines
  • Monitoring Systems
  • Cannulas
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Getinge AB
  • Medtronic
  • LivaNova PLC
  • XVIVO Perfusion
  • Terumo Cardiovascular Systems Corporation
  • OrganOx Limited
  • Waters Medical Systems
  • TransMedics
  • Organ Recovery Systems
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Technique , Organ Type , and Component , and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions

What are Medical Perfusion Technology?

Perfusion is the passage of fluid through the circulatory system or lymphatic system to an organ or a tissue, usually referring to the delivery of blood to a capillary bed in tissue. Perfusion is measured as the rate at which blood is delivered to tissue, or volume of blood per unit time (blood flow) per unit tissue mass. During major surgery, perfusion must be maintained and managed by the health professionals involved, rather than left to the body's homeostasis alone.

What are the driving factors for the Medical Perfusion Technology market across the globe?

Key factors that are driving the market are rising prevalence of cardiovascular diseases, significant growth of pharmaceutical and biotechnology industries, rising need for the organ transplantation and rising cell-based research activities. However, challenging factors such as expensive organ transplant surgeries and limited numbers of donors for organ transplant surgeries are likely to show negative impact for the market in few years ahead.

What is the cost of Medical Perfusion Technology?

The costs of the medical perfusion technology are much higher, and they may cost US$ 1,0000–5,0000, or more, per software. The cost may also differ from product to product types.

The List of Companies - Medical Perfusion Technology Market

  1. Getting AB
  2. Medtronic              
  3. LivaNova PLC        
  4. Terumo Corporation          
  5. XVIVO Perfusion                 
  6. OrganOx Limited                 
  7. Waters Medical Systems LLC          
  8. TransMedics         
  9. Organ Recovery Systems                 
  10. Xenios AG - a Fresenius Medical Care company

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Medical Perfusion Technology Market